Literature DB >> 4688573

Methyldopa hepatitis. Report of three cases.

A M Hoyumpa, A M Connell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4688573     DOI： 10.1007/bf01071975

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN： 0002-9211


× No keyword cloud information.
  29 in total

1.  ALPHA-METHYLDOPA AND HYDROCHLOROTHIAZIDE. A CONTROLLED STUDY OF THEIR COMPARATIVE EFFECTIVENESS AS ANTIHYPERTENSIVE AGENTS.

Authors:  J M COLWILL; A M DUTTON; J MORRISSEY; P N YU
Journal:  N Engl J Med       Date:  1964-10-01       Impact factor: 91.245

2.  THE PLACE OF METHYLDOPA IN THE TREATMENT OF SEVERE HYPERTENSION.

Authors:  J CONWAY; A J ZWEIFLER; S JULIUS
Journal:  JAMA       Date:  1963-10-19       Impact factor: 56.272

3.  METHYLDOPA IN THE TREATMENT OF HYPERTENSION.

Authors:  B L GILMORE; E D FREIS
Journal:  Med Ann Dist Columbia       Date:  1965-01

4.  TREATMENT OF HYPERTENSION WITH METHYLDOPA ALONE OR COMBINED WITH DIURETICS AND OR GUANETHIDINE. A REPORT OF 63 CASES.

Authors:  J W LEONARD; R W GIFFORD; D C HUMPHREY
Journal:  Am Heart J       Date:  1965-05       Impact factor: 4.749

5.  Antihypertensive agent.

Authors:  M S KLAPPER; L RICHARD
Journal:  Med Times       Date:  1963-02

6.  Treatment of severe hypertension with methyldopa.

Authors:  M HAMILTON; H KOPELMAN
Journal:  Br Med J       Date:  1963-01-19

7.  Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.

Authors:  T B Reynolds; R L Peters; S Yamada
Journal:  N Engl J Med       Date:  1971-10-07       Impact factor: 91.245

8.  Comparison of bethanidine, alpha-methyldopa, and reserpine in essential hypertension.

Authors:  W E Gibb; J S Malpas; P Turner; R J White
Journal:  Lancet       Date:  1970-08-08       Impact factor: 79.321

9.  Effects of methyldopa in fifty hypertensive patients.

Authors:  D Horwitz; W A Pettinger; H Orvis; R E Thomas; A Sjoerdsma
Journal:  Clin Pharmacol Ther       Date:  1967 Mar-Apr       Impact factor: 6.875

10.  A within-patient comparison of debrisoquine and methyldopa in hypertension.

Authors:  A Heffernan; A Carty; K O'Malley; J Bugler
Journal:  Br Med J       Date:  1971-01-09
View more
  8 in total

1.  Severe hepatic necrosis associated with methyldopa.

Authors:  I A Cameron; J L Achord; H Bartee
Journal:  Can Fam Physician       Date:  1981-04       Impact factor: 3.275

2.  Drug choice for treatment of hypertension at 'step 2'.

Authors:  L Z Feigenbaum
Journal:  West J Med       Date:  1979-04

Review 3.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

4.  Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

5.  Active chronic hepatitis. Part I.

Authors:  T Fulton; V J McCann
Journal:  Ulster Med J       Date:  1976

6.  Autoimmune hepatitis triggered by nitrofurantoin: a case series.

Authors:  Sally Appleyard; Ruma Saraswati; David A Gorard
Journal:  J Med Case Rep       Date:  2010-09-23

7.  Methyldopa liver damage.

Authors:  P J Toghill; P G Smith; P Benton; R C Brown; H L Matthews
Journal:  Br Med J       Date:  1974-08-31

Review 8.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.